Position in OGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$238,642
+$142,928 QoQ
Shares Held
17,625
+10.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#225
of 625 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $158,372,063 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,798 | $35,740,618 | |
| 2 | JNJ |
Johnson & Johnson
|
140,570 | $35,700,562 | |
| 3 | ABBV |
AbbVie Inc.
|
105,320 | $26,502,724 | |
| 4 | MRK |
Merck & Co., Inc.
|
129,070 | $16,585,495 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
128,422 | $7,399,675 | |
| 6 | AMGN |
Amgen Inc
|
18,320 | $6,634,038 | |
| 7 | NVS |
Novartis AG
|
39,193 | $6,142,326 | |
| 8 | NVO |
Novo Nordisk A S
|
121,486 | $5,824,038 |
All Filings in OGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,642 | 17,625 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $95,714 | 15,979 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $154,710 | 14,486 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $132,015 | 13,638 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $355,945 | 23,905 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $313,140 | 20,988 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $626,851 | 32,768 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $570,761 | 27,573 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||